Molecular Signatures Are Redefining Cancer Treatment
New studies demonstrate that treating cancer based on its molecular vulnerabilities, rather than where it originated, could translate to better outcomes for patients
genomics
Most Genome Data Comes from White Folks. Scientists Are Trying to Fix That.
With a new genome sequence, more diverse data sets, and population-specific projects, scientists are making progress in representing humanity’s real DNA diversity.
Doctors Finally Care About Your Home DNA Results
After years of dismissing direct-to-consumer genetic tests, some healthcare professionals are now seeking guidelines for how to incorporate this data into patient care.
A Breakthrough Cancer Therapy Targets Autoimmune Diseases
CAR T therapies juice the immune system. In cancer, they have cured patients who had little hope for survival. Now scientists are asking "What else can they do?"
AI, Digital Gene Editing & Fusion: What Comes Next For NFTs
NFTs have entered a new stage of their life cycle—and the possibilities are endless for this next generation, aptly called Living NFTs.
Can CRISPR Solve Covid Testing?
Scientists are using elements of the gene editing technology to develop rapid, accurate tests for infectious diseases, including Covid-19.
Blood Test Shows Promise for Detecting Cancer Far Earlier
Scientists in Ontario used machine learning techniques to find telltale signs of cancer in blood samples that were collected up to seven years prior to conventional diagnosis.
Scientists ID Genetic Risk Factors For Suicide
While any suicide attempt is triggered by a complex array of factors, new studies indicate that genetic variants contribute to a person’s risk. That could pave the way for new treatments or diagnostic tests.
Genetic Tests Won’t Predict Your COVID-19 Risk
Tests that claim to predict someone’s susceptibility to COVID-19 based on genetic data don’t work, researchers found. That’s partly because there is as yet no scientific consensus on what constitutes genetic risk.
